Nuberg Wins Chlor-alkali Project in India

Indian chemical plant contractor Nuberg EPC has been tapped to build a 250 t/d chlor-alkali plant planned by Indian chemical major Chemfab Alkalis at Karaikal, Puducherry.

The project, for which no investment cost nor contract value have been announced, is expected to be completed in 22 months. It will be the engineering firm’s first greenfield caustic soda project delivery in India.

Nuberg said it is taking on the project under an Engineering, Procurement, and Construction Management (EPCM) service-based contract.

The facility will use the latest bi-polar membrane based electrolysis system technology, Bipolar Membrane Cell Technology Electrolyzer. With this, the contractor said, production can be easily upgraded to the latest developments in future. Moreover, the plant will need little maintenance.

At Karaikal, Chemfab Alkis will produce caustic soda, hydrochloric acid, sodium hypochlorite, anhydrous sodium sulphate and soda ash lye that will be used by the textile, aluminum, paper and pulp sectors as well as water industries.

Author: Dede Williams, Freelance Journalist

The project will be Nuberg EPCs first greenfield Caustic Soda project delivery...
The project will be Nuberg EPC's first greenfield Caustic Soda project delivery in India. © Nuberg EPC

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read